# Armata Pharmaceuticals, Inc.: Form 4, filed Jan 12, 2023

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 4
- Filed: 2023-01-12
- Accepted by EDGAR: Jan 12, 2023, 21:21 ET
- Period: 2023-01-10
- Accession: 0001104659-23-003540
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000110465923003540/xslF345X03/tm232524-2_4seq1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000110465923003540/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000110465923003540/xslF345X03/tm232524-2_4seq1.xml

Filed Jan 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-003540. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.